Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals

5.0k indexed citations

Abstract

loading...

About

This paper, published in 2014, received 5.0k indexed citations. Written by Edon Vitaku, David T. Smith and Jón T. Njardarson covering the research area of Organic Chemistry and Molecular Biology. It is primarily cited by scholars working on Organic Chemistry (4.5k citations), Inorganic Chemistry (851 citations) and Molecular Biology (802 citations). Published in Journal of Medicinal Chemistry.

Countries where authors are citing Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals

Specialization
Citations

This map shows the geographic impact of Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals more than expected).

Fields of papers citing Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1021/jm501100b.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026